Amend CSHB 21 (house committee report) as follows:
(1) On page 1, strike line 19 and substitute the following:
life-saving treatment to patients with a terminal illness;
(2) On page 3, strike lines 17-26 and substitute the following:
Sec. 489.052. INFORMED CONSENT. (a) Before receiving an investigational drug, biological product, or device, an eligible patient must sign a written informed consent described by this section that is attested to by the patient's physician and a witness.
(b) If the patient is a minor or lacks the mental capacity to provide informed consent, a parent, guardian, or conservator may provide informed consent on the patient's behalf.
(c) The executive commissioner of the Health and Human Services Commission, in collaboration with the Texas Medical Board, by rule shall adopt a form for the informed consent required under this section.
(3) Add the following appropriately numbered SECTION to the bill and renumber subsequent SECTIONS of the bill accordingly:
SECTION ____. The executive commissioner of the Health and Human Services Commission by rule shall adopt the form for informed consent as required by Section 489.052(c), Health and Safety Code, as added by this Act, not later than the 30th day after the effective date of this Act.